LAMBERTUCCI, Catia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.555
EU - Europa 871
AS - Asia 608
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 13
SA - Sud America 13
AF - Africa 8
Totale 3.110
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.503
CN - Cina 323
IT - Italia 225
DE - Germania 148
GB - Regno Unito 140
JP - Giappone 100
RU - Federazione Russa 68
FR - Francia 66
IN - India 43
AU - Australia 42
CA - Canada 41
PL - Polonia 40
HK - Hong Kong 36
NL - Olanda 27
CZ - Repubblica Ceca 26
VN - Vietnam 26
ES - Italia 19
KR - Corea 16
BE - Belgio 14
CH - Svizzera 13
AP - ???statistics.table.value.countryCode.AP??? 12
IR - Iran 12
FI - Finlandia 11
IE - Irlanda 11
SG - Singapore 11
UA - Ucraina 11
MX - Messico 9
SE - Svezia 9
DK - Danimarca 8
LT - Lituania 7
PT - Portogallo 7
TW - Taiwan 7
MO - Macao, regione amministrativa speciale della Cina 6
RO - Romania 6
BR - Brasile 5
BD - Bangladesh 4
IL - Israele 4
ZA - Sudafrica 4
AR - Argentina 3
CL - Cile 3
GR - Grecia 3
PH - Filippine 3
PK - Pakistan 3
TR - Turchia 3
CR - Costa Rica 2
HU - Ungheria 2
ID - Indonesia 2
IQ - Iraq 2
IS - Islanda 2
MA - Marocco 2
RS - Serbia 2
SA - Arabia Saudita 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BY - Bielorussia 1
EG - Egitto 1
EU - Europa 1
GH - Ghana 1
HR - Croazia 1
JO - Giordania 1
LB - Libano 1
MT - Malta 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 3.110
Salva come PNG Salva come JPEG
Città #
Houston 197
Fairfield 140
Ashburn 103
Cambridge 83
Santa Cruz 75
Camerino 74
Ann Arbor 69
Seattle 67
Shanghai 53
Wilmington 50
Woodbridge 50
Buffalo 47
Beijing 42
Wuhan 34
Warsaw 32
Dong Ket 24
New York 24
San Diego 21
Tokyo 20
Leawood 19
Centro 18
Bengaluru 17
Los Angeles 17
Jinan 16
Pavia 16
Hangzhou 15
Las Vegas 15
Milan 14
Ottawa 14
Guangzhou 13
Moscow 13
Chicago 12
Falls Church 12
Sakurai 12
Chengdu 11
Dublin 10
Nanjing 9
Paris 9
Shenyang 9
Linden 8
London 8
St Petersburg 8
Toronto 8
Dallas 7
Madrid 7
Manchester 7
Nürnberg 7
San Francisco 7
Scafati 7
Amsterdam 6
Bendigo 6
Bologna 6
Columbus 6
Council Bluffs 6
Duncan 6
Frankfurt am Main 6
Hamburg 6
Hong Kong 6
Melbourne 6
Milpitas 6
Mumbai 6
Nizhniy Novgorod 6
Osaka 6
Portland 6
Adelaide 5
Boulder 5
Brooklyn 5
Central 5
Helsinki 5
Lake Forest 5
Madison 5
Maletto 5
Menlo Park 5
Passau 5
Pittsburgh 5
Provo 5
Taipei 5
Xian 5
Ashiharacho 4
Athens 4
Berlin 4
Boston 4
Brussels 4
Crugers 4
Frankfurt Am Main 4
Gatchina 4
Gurgaon 4
Minneapolis 4
Parsippany 4
Randwick 4
San Jose 4
Sydney 4
Volgograd 4
Aachen 3
Albuquerque 3
Arcevia 3
Austin 3
Barcelona 3
Basel 3
Bedworth 3
Totale 1.791
Salva come PNG Salva come JPEG
Nome #
Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications, file e0ff0074-2c06-9bac-e053-1705fe0af019 761
The G Protein-Coupled Receptor GPR17: Overview and Update, file e0ff0072-b0e8-9bac-e053-1705fe0af019 449
GPR17 receptor modulators and their therapeutic implications: review of recent patents, file e0ff0074-a9fe-9bac-e053-1705fe0af019 373
Overview on Radiolabel-Free in Vitro Assays for GPCRs, file e0ff0072-ac8f-9bac-e053-1705fe0af019 296
The Length and Flexibility of the 2-Substituent of 9-Ethyladenine Derivatives Modulate Affinity and Selectivity for the Human A2A Adenosine Receptor, file e0ff0072-b2fb-9bac-e053-1705fe0af019 210
The aminopyridine-3,5-dicarbonitrile core for the design of new non-nucleoside-like agonists of the human adenosine A2B receptor, file e0ff0073-08ff-9bac-e053-1705fe0af019 201
New sensible method to quantize the intestinal absorption of receptor ligands, file e0ff0073-da40-9bac-e053-1705fe0af019 180
Fragment optimization for GPCRs by molecular dynamics free energy calculations: Probing druggable subpockets of the A2A adenosine receptor binding site, file e0ff0072-efd7-9bac-e053-1705fe0af019 106
Neuroprotective potential of adenosine A1 receptor partial agonists in experimental models of cerebral ischemia, file e0ff0074-474a-9bac-e053-1705fe0af019 106
Non-Nucleoside Agonists of the Adenosine Receptors: An Overview, file e0ff0073-f268-9bac-e053-1705fe0af019 96
Investigation on 2′,3′-O-Substituted ATP Derivatives and Analogs as Novel P2X3 Receptor Antagonists, file e0ff0074-415d-9bac-e053-1705fe0af019 90
Investigation on 2′,3′-O-Substituted ATP Derivatives and Analogs as Novel P2X3 Receptor Antagonists, file e0ff0074-415e-9bac-e053-1705fe0af019 70
Purinergic Ligands as Potential Therapeutic Tools for the Treatment of Inflammation-Related Intestinal Diseases, file e0ff0073-1410-9bac-e053-1705fe0af019 63
2′,3′-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents, file e0ff0073-9499-9bac-e053-1705fe0af019 63
A2AR agonists/A3R antagonists: design, synthesis, and biological evaluation of new ligands with dual activity, file e0ff0073-0c0b-9bac-e053-1705fe0af019 27
2’,3’-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents, file e0ff0073-0fb8-9bac-e053-1705fe0af019 16
Approaches for designing and discovering purinergic drugs for gastrointestinal diseases, file 1b8ef5ed-7704-47fa-94d5-f5e9cbbfb953 15
Pharmacological characterization of the GPR17 receptor dual profile, file e0ff0073-08ed-9bac-e053-1705fe0af019 13
A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable?, file e0ff0074-fba5-9bac-e053-1705fe0af019 6
A patent review of adenosine A2B receptor antagonists (2016-present), file 98ec94e8-7aff-4f03-aee8-17e3f5b17930 5
Adenosine Receptors as Neuroinflammation Modulators: Role of A1 Agonists and A2A Antagonists, file e0ff0074-9ad4-9bac-e053-1705fe0af019 5
Combined therapy of A1AR agonists and A2AAR antagonists in neuroinflammation, file e0ff0074-e319-9bac-e053-1705fe0af019 5
Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease, file e0ff0074-e372-9bac-e053-1705fe0af019 5
The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A3 Receptor Agonist, in a Rat Model of Colitis, file e0ff0074-9ad2-9bac-e053-1705fe0af019 4
P2X3 Receptor Ligands: Structural Features and Potential Therapeutic Applications, file e0ff0074-e31b-9bac-e053-1705fe0af019 4
Purinergic P2X receptors: Structural models and analysis of ligand-target interaction, file e0ff0072-5f55-9bac-e053-1705fe0af019 3
Antiproliferative Evaluation of Isofuranodiene on Breast and Prostate Cancer Cell Lines, file e0ff0072-8f11-9bac-e053-1705fe0af019 3
Biomarkers mapping of neuropathic pain in a nerve chronic constriction injury mice model, file e0ff0073-c8f6-9bac-e053-1705fe0af019 3
Anticancer activity study of A3 adenosine receptor agonists, file e0ff0073-d80d-9bac-e053-1705fe0af019 3
Regulation of adenosine A2A receptor gene expression in a model of binge eating in the amygdaloid complex of female rats, file e0ff0074-2d33-9bac-e053-1705fe0af019 3
Multipotent stromal cells from subcutaneous adipose tissue of normal weight and obese subjects: Modulation of their adipogenic differentiation by adenosine A1 receptor ligands, file e0ff0074-eb4c-9bac-e053-1705fe0af019 3
Medicinal Chemistry of P2X Receptors: Agonists and Orthosteric Antagonists, file e0ff0072-61d5-9bac-e053-1705fe0af019 2
Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors, file e0ff0072-9bb8-9bac-e053-1705fe0af019 2
Simulation and Comparative Analysis of Different Binding Modes of Non-nucleoside Agonists at the A2A Adenosine Receptor, file e0ff0072-aa02-9bac-e053-1705fe0af019 2
New potent and selective A1 adenosine receptor antagonists as potential tools for the treatment of gastrointestinal diseases, file e0ff0073-1500-9bac-e053-1705fe0af019 2
Approaches for designing and discovering purinergic drugs for gastrointestinal diseases, file 59420ae7-5e97-4e1d-8aa4-2ee674ed2158 1
Molecular modeling study on potent and selective adenosine A3 receptor agonists., file e0ff0072-4db4-9bac-e053-1705fe0af019 1
New substituted 9-propyladenine derivatives as A2Aadenosine receptor antagonists, file e0ff0072-61d6-9bac-e053-1705fe0af019 1
Biomarkers Mapping in a Neuropathic Pain Mice Model with Sciatic Nerve Chronic Constriction Injury (CCI)., file e0ff0072-912a-9bac-e053-1705fe0af019 1
Evidence for the existence of a specific G protein-coupled receptor activated by guanosine, file e0ff0072-b6e7-9bac-e053-1705fe0af019 1
Human cytidine deaminase: understanding the catalytic mechanism, file e0ff0072-c7d2-9bac-e053-1705fe0af019 1
Synthesis, Characterization, and Biological Activity of Purine and Pyrimidine Nucleoside and Nucleotide Analogues, file e0ff0072-f78f-9bac-e053-1705fe0af019 1
Ex-vivo absorption study of lysine R-lipoate salt, a new pharmaceutical form of R-ALA, file e0ff0073-14fe-9bac-e053-1705fe0af019 1
Simulation and Comparative Analysis of Different Binding Modes of Non-nucleoside Agonists at the A2A Adenosine Receptor, file e0ff0073-8dda-9bac-e053-1705fe0af019 1
The aminopyridine-3,5-dicarbonitrile core for the design of new non-nucleoside-like agonists of the human adenosine A2B receptor, file e0ff0074-5816-9bac-e053-1705fe0af019 1
New A2A adenosine receptor antagonists: a structure-based upside-down interaction in the receptor cavity, file e0ff0074-a47d-9bac-e053-1705fe0af019 1
A3 Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity, file e0ff0074-dcbe-9bac-e053-1705fe0af019 1
Totale 3.207
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.172
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.172
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201939 0 0 0 0 0 0 0 0 0 9 18 12
2019/2020198 9 12 9 25 13 9 13 13 16 9 30 40
2020/2021701 24 38 36 31 44 70 79 47 68 91 89 84
2021/20221.146 115 123 66 155 118 88 82 63 52 68 144 72
2022/2023513 29 51 108 80 45 40 22 17 21 33 40 27
2023/2024565 60 79 46 61 81 34 48 54 58 44 0 0
Totale 3.207